| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 1090 | 96 |
| GSM780708 | Untreated after 4 days (C2_1) | 1227.58 | 96 |
| GSM780709 | Untreated after 4 days (C3_1) | 1526.64 | 97 |
| GSM780719 | Untreated after 4 days (C1_2) | 1230.68 | 96 |
| GSM780720 | Untreated after 4 days (C2_2) | 1201.81 | 96 |
| GSM780721 | Untreated after 4 days (C3_2) | 1499.87 | 97 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 1108.45 | 96 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 1233.71 | 96 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 859.105 | 95 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 1246.13 | 96 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 1161.34 | 96 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 885.379 | 95 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 1281.89 | 97 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 1180.57 | 96 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 1317.47 | 97 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 1260.13 | 96 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 1151.88 | 96 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 1168.82 | 96 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 1243.62 | 96 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 1150.08 | 96 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 1134.02 | 96 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 1253.23 | 96 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 1187.53 | 96 |